Twist Bioscience Stock Soars, Hits New Highs

Twist Bioscience (TWST), a biotechnology company valued at $10.47 billion, has demonstrated exceptional performance over the last 52 weeks, with its stock price increasing by 493.58%. The company focuses on synthetic DNA products, including synthetic genes and antibody libraries for drug discovery, and even explores DNA for digital data storage. On September 21, 2026, TWST achieved an all-time high of $170.23. Its technical indicators show a strong positive trend, with a 100% "Buy" opinion from Barchart and a recent "Buy" signal from Trend Seeker on August 3, 2026. Since that signal, the stock has gained 63.84%.

However, some indicators suggest TWST might be overextended. Its Relative Strength Index (RSI) is at 71.67, and high short interest warrants caution. While revenue is projected to grow by 21.19% this year, it is expected to decrease by 18.41% next year. Earnings are forecast to increase by 71.648% in the current year, with a slight decrease of 5.42% anticipated next year. Despite these concerns, the stock continues to show strong technical momentum.